Fecal Microbiota Transplantation for Chronic Pouchitis: A Systematic Review and Meta-Analysis
Author Information
Author(s): Chun Magnus, Tun Kyaw Min, Vongsavath Tahne, Verma Renuka, Batra Kavita, Limsui David, Jenkins Erin
Primary Institution: Kirk Kerkorian School of Medicine at UNLV, University of Nevada, Las Vegas, NV, USA
Hypothesis
This study aims to evaluate outcomes and complications of fecal microbiota transplantation (FMT) for chronic pouchitis.
Conclusion
FMT is an effective treatment for chronic pouchitis, but there is a high rate of mild adverse events.
Supporting Evidence
- The pooled overall remission rate was 15%.
- The clinical response rate was 33%.
- The clinical remission rate was 14%.
- The clinical relapse rate was 36%.
- 39% of patients experienced mild adverse events after FMT treatment.
Takeaway
Doctors are trying a new treatment called fecal microbiota transplantation to help people with pouchitis, which is a problem that can happen after surgery for ulcerative colitis. It seems to help some people, but many still feel a little sick afterward.
Methodology
The study systematically searched databases for English-only original studies on chronic pouchitis and included seven studies with a total of 94 patients.
Potential Biases
Variability in definitions of clinical response and remission across studies.
Limitations
High-level evidence for FMT is still sparse, limiting recommendations for clinical use.
Participant Demographics
The sample included 33 males and 45 females, with the age range from 6 to 26 years old.
Statistical Information
P-Value
p < 0.001
Confidence Interval
95% CI: 0–29%
Statistical Significance
p < 0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website